Methodological and analytical considerations for intra-operative microdialysis
Authors:
Open Access
- 19 December 2023
- journal article
- research article
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 20 (1) , 1-17
Abstract
Background: Microdialysis is a technique that can be utilized to sample the interstitial fluid of the central nervous system (CNS), including in primary malignant brain tumors known as gliomas. Gliomas are mainly accessible at the time of surgery, but have rarely been analyzed via interstitial fluid collected via microdialysis. To that end, we obtained an investigational device exemption for high molecular weight catheters (HMW, 100 kDa) and a variable flow rate pump to perform microdialysis at flow rates amenable to an intra-operative setting. We herein report on the lessons and insights obtained during our intra-operative HMW microdialysis trial, both in regard to methodological and analytical considerations. Methods: Intra-operative HMW microdialysis was performed during 15 clinically indicated glioma resections in fourteen patients, across three radiographically diverse regions in each patient. Microdialysates were analyzed via targeted and untargeted metabolomics via ultra-performance liquid chromatography tandem mass spectrometry. Results: Use of albumin and lactate-containing perfusates impacted subsets of metabolites evaluated via global metabolomics. Additionally, focal delivery of lactate via a lactate-containing perfusate, induced local metabolic changes, suggesting the potential for intra-operative pharmacodynamic studies via reverse microdialysis of candidate drugs. Multiple peri-operatively administered drugs, including levetiracetam, cefazolin, caffeine, mannitol and acetaminophen, could be detected from one microdialysate aliquot representing 10 min worth of intra-operative sampling. Moreover, clinical, radiographic, and methodological considerations for performing intra-operative microdialysis are discussed. Conclusions: Intra-operative HMW microdialysis can feasibly be utilized to sample the live human CNS microenvironment, including both metabolites and drugs, within one surgery. Certain variables, such as perfusate type, must be considered during and after analysis. Trial registration NCT04047264Keywords
Funding Information
- National Institutes of Health (T32GM145408)
- National Cancer Institute (CA276851)
- National Institute of Neurological Disorders and Stroke (NS122096)
- Center for Clinical and Translational Science, Mayo Clinic (UL1TR002377)
- American Brain Tumor Association
- Brains Together For a Cure
- Humor to Fight the Tumor
- Lucius and Terrie McKelvey
This publication has 39 references indexed in Scilit:
- Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injuryJournal of Neurosurgery, 2010
- Intra-operative, real-time, three-dimensional ultrasound assisted positioning of catheters in the microdialysis of glial tumoursJournal of Clinical Neuroscience, 2010
- Metabolomic Patterns in Glioblastoma and Changes during Radiotherapy: A Clinical Microdialysis StudyJournal of Proteome Research, 2010
- Detection and Quantification of Neurotransmitters in DialysatesCurrent Protocols in Neuroscience, 2009
- Overview of Brain MicrodialysisCurrent Protocols in Neuroscience, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: A microdialysis study*Critical Care Medicine, 2008
- Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury*Critical Care Medicine, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Stabilization of Human Albumin by Caprylate and AcetyltryptophanateVox Sanguinis, 1984